Peel Hunt Reiterates “Buy” Rating for CVS Group (CVSG)

Peel Hunt restated their buy rating on shares of CVS Group (LON:CVSG) in a research report released on Monday morning.

CVSG has been the topic of several other research reports. Royal Bank of Canada decreased their price target on CVS Group from GBX 1,190 ($15.55) to GBX 1,180 ($15.42) and set an outperform rating on the stock in a research note on Tuesday, October 23rd. Berenberg Bank cut their price objective on CVS Group from GBX 1,450 ($18.95) to GBX 1,250 ($16.33) and set a buy rating on the stock in a report on Monday, October 1st.

CVS Group stock opened at GBX 682 ($8.91) on Monday. CVS Group has a one year low of GBX 13.22 ($0.17) and a one year high of GBX 1,500 ($19.60).

In other news, insider Richard Fairman acquired 1,450 shares of the company’s stock in a transaction that occurred on Monday, December 3rd. The shares were acquired at an average price of GBX 651 ($8.51) per share, for a total transaction of £9,439.50 ($12,334.38).

About CVS Group

CVS Group plc engages in veterinary, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practice, Laboratory, Crematoria, and Animed Direct. It operates animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation services for veterinary practices and directly for pet owners; and clinical waste collection services, as well as specialist veterinary recruitment services.

See Also: The risks of owning bonds

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply